» Articles » PMID: 29023938

A Pharmacist-Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV-Positive Patients

Overview
Journal Pharmacotherapy
Specialty Pharmacology
Date 2017 Oct 13
PMID 29023938
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The goal of this pharmacist-led study was to utilize two validated instruments, Beers Criteria and Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP), to assess potentially inappropriate prescribing (PIP) in older patients infected with the human immunodeficiency virus (HIV) and evaluate pharmacist interventions.

Design: Prospective randomized interventional trial.

Setting: Large urban clinic providing interdisciplinary primary and HIV care for ~2700 HIV-positive publicly insured patients.

Data Source: A computerized electronic record search was conducted for all patients who met the two search criteria: 50 years and older, and a primary care appointment within the last 12 months.

Patients: After identification of 857 patients meeting the search criteria, 324 patients were randomly selected and contacted, resulting in 248 patients assessed.

Measurements And Main Results: Patients had a mean age of 58 years, 71% male, 44% white, and a mean CD4 count of 536 cells/mm . Common comorbidities included hypertension (56%), depression (52%), asthma/chronic obstructive pulmonary disease (48%), dyslipidemia (39%), coronary artery disease (27%), and diabetes (22%). Patients sampled were prescribed a mean of 11.6 ± 5.7 concomitant medications (excluding antiretrovirals) with 35% receiving at least 16 medications. PIP was identified in 54% and 63% of patients using the STOPP and Beers Criteria, respectively. Twenty-five contraindicated drug interactions were identified in 20 patients. After the pharmacist visit, at least 69% of patients had at least one medication discontinued with almost 10% having six or more medications discontinued. More than 40% of patients had at least one Beers or STOPP criteria that required immediate correction by the pharmacist.

Conclusions: Results suggest that targeting individuals with 11 or more chronic medications would have the highest yield and greatest impact. Pharmacist-led review of medication prescribing using Beers and STOPP criteria revealed a large number of PIP, many amenable to immediate clinical pharmacist intervention.

Citing Articles

Effectiveness, safety, and patient-reported outcomes of bictegravir/emtricitabine/tenofovir alafenamide in routine clinical care in Italy: 12-Month results from the BICSTaR cohort.

Antinori A, Marchetti G, Esposito V, Rusconi S, Canetti D, Quiros-Roldan E Int J STD AIDS. 2025; 36(4):309-318.

PMID: 39772928 PMC: 11877974. DOI: 10.1177/09564624241308372.


Prevalence of medication overload among older people with HIV: a MedSafer study.

Bortolussi-Courval E, Smyth E, Costiniuk C, Falutz J, Ross S, Liu K BMC Infect Dis. 2024; 24(1):1204.

PMID: 39455936 PMC: 11520045. DOI: 10.1186/s12879-024-10105-9.


The prevalence of antiretroviral drug interactions with other drugs used in women living with HIV and its association with HIV drug change and patient compliance.

Heydari M, Foroozanfar Z, Bazmi S, Mohammadi Z, Joulaei H, Ansari G BMC Infect Dis. 2024; 24(1):1123.

PMID: 39379848 PMC: 11462963. DOI: 10.1186/s12879-024-09958-x.


Role of the pharmacist caring for people at risk of or living with HIV in Canada.

Tkachuk S, Ready E, Chan S, Hawkes J, Janzen Cheney T, Kapler J Can Pharm J (Ott). 2024; 157(5):218-239.

PMID: 39310805 PMC: 11412478. DOI: 10.1177/17151635241267350.


Patient and clinician preferences for diabetes management among older adults with co-morbid HIV: A qualitative exploration.

Pack A, Masters M, OConor R, Alcantara K, Svoboda S, Smith R PLoS One. 2024; 19(5):e0303499.

PMID: 38743699 PMC: 11093335. DOI: 10.1371/journal.pone.0303499.